318 related articles for article (PubMed ID: 25753458)
1. Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
Muellner J; Gharrad I; Habert MO; Kas A; Martini JB; Cormier-Dequaire F; Tahiri K; Vidailhet M; Meier N; Brice A; Schuepbach M; Mallet A; Hartmann A; Corvol JC
Parkinsonism Relat Disord; 2015 May; 21(5):471-6. PubMed ID: 25753458
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
[TBL] [Abstract][Full Text] [Related]
3. The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
Corvol JC; Bonnet C; Charbonnier-Beaupel F; Bonnet AM; Fiévet MH; Bellanger A; Roze E; Meliksetyan G; Ben Djebara M; Hartmann A; Lacomblez L; Vrignaud C; Zahr N; Agid Y; Costentin J; Hulot JS; Vidailhet M
Ann Neurol; 2011 Jan; 69(1):111-8. PubMed ID: 21280081
[TBL] [Abstract][Full Text] [Related]
4. The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study.
Wu K; O'Keeffe D; Politis M; O'Keeffe GC; Robbins TW; Bose SK; Brooks DJ; Piccini P; Barker RA
Brain; 2012 Aug; 135(Pt 8):2449-57. PubMed ID: 22843413
[TBL] [Abstract][Full Text] [Related]
5. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
Klebe S; Golmard JL; Nalls MA; Saad M; Singleton AB; Bras JM; Hardy J; Simon-Sanchez J; Heutink P; Kuhlenbäumer G; Charfi R; Klein C; Hagenah J; Gasser T; Wurster I; Lesage S; Lorenz D; Deuschl G; Durif F; Pollak P; Damier P; Tison F; Durr A; Amouyel P; Lambert JC; Tzourio C; Maubaret C; Charbonnier-Beaupel F; Tahiri K; Vidailhet M; Martinez M; Brice A; Corvol JC; ;
J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):666-73. PubMed ID: 23408064
[TBL] [Abstract][Full Text] [Related]
6. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.
Wu H; Dong F; Wang Y; Xiao Q; Yang Q; Zhao J; Quinn TJ; Chen SD; Liu J
Parkinsonism Relat Disord; 2014 Oct; 20(10):1094-6. PubMed ID: 25108642
[TBL] [Abstract][Full Text] [Related]
8. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
[TBL] [Abstract][Full Text] [Related]
9. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism.
Foltynie T; Goldberg TE; Lewis SG; Blackwell AD; Kolachana BS; Weinberger DR; Robbins TW; Barker RA
Mov Disord; 2004 Aug; 19(8):885-91. PubMed ID: 15300652
[TBL] [Abstract][Full Text] [Related]
10. Gender-dependent association of the functional catechol-O-methyltransferase Val158Met genotype with sensation seeking personality trait.
Lang UE; Bajbouj M; Sander T; Gallinat J
Neuropsychopharmacology; 2007 Sep; 32(9):1950-5. PubMed ID: 17299513
[TBL] [Abstract][Full Text] [Related]
11. COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndrome.
Boot E; Booij J; Zinkstok JR; Baas F; Swillen A; Owen MJ; Murphy DG; Murphy KC; Linszen DH; Van Amelsvoort TA
Synapse; 2011 Sep; 65(9):967-70. PubMed ID: 21465565
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase Val158Met polymorphism (rs4680) is associated with pain in multiple sclerosis.
Fernández-de-las-Peñas C; Ambite-Quesada S; Ortíz-Gutiérrez R; Ortega-Santiago R; Gil-Crujera A; Caminero AB
J Pain; 2013 Dec; 14(12):1719-23. PubMed ID: 24290452
[TBL] [Abstract][Full Text] [Related]
13. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
[TBL] [Abstract][Full Text] [Related]
14. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
15. Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease.
Sampedro F; Marín-Lahoz J; Martínez-Horta S; Camacho V; Lopez-Mora DA; Pagonabarraga J; Kulisevsky J
Neurobiol Aging; 2021 Jan; 97():120-128. PubMed ID: 33212336
[TBL] [Abstract][Full Text] [Related]
16. Double dissociation of dopamine genes and timing in humans.
Wiener M; Lohoff FW; Coslett HB
J Cogn Neurosci; 2011 Oct; 23(10):2811-21. PubMed ID: 21261454
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis.
Watanabe K; Kakeda S; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umene-Nakano W; Watanabe R; Nakamura J; Korogi Y
Psychiatry Res; 2015 Sep; 233(3):481-7. PubMed ID: 26253436
[TBL] [Abstract][Full Text] [Related]
18. Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.
Liu J; Chen P; Guo M; Lu L; Li L
Neurol Sci; 2015 Apr; 36(4):621-3. PubMed ID: 25367407
[TBL] [Abstract][Full Text] [Related]
19. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
20. The COMT val158met polymorphism is associated with prevalent fractures in Swedish men.
Eriksson AL; Mellström D; Lorentzon M; Orwoll ES; Redlund-Johnell I; Grundberg E; Holmberg A; Ljunggren O; Karlsson MK; Ohlsson C
Bone; 2008 Jan; 42(1):107-12. PubMed ID: 17962094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
